Pipeline

You are here

The Iproteos pipeline is currently focused on Cognitive Impairment Associated with Schizophrenia (CIAS), epilepsypaediatric cancer and atherosclerosis -four diseases with a high social and economic impact worldwide.

Our candidates are in preclinical phases of drug development, as reflected in the chart below: